Todd Grazia is a Respiratory physician affiliated with Baylor University Medical Center. OpenAlex indexes 45 publications with 888 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3410 Worth St.
Suite 250
Dallas, TX 75246
Telephone
214-820-6856Provider last certified this registry record 26 May 2023.
Clinical trials
- Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation
Sponsor: University of Colorado, Denver
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Invivyd IncProgram year20251 payment
- La Jolla Pharmaceutical CompanyProgram year20256 payments
- Insmed, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
33.4%Macrolide Antimicrobial8.6%Azithromycin100%Part D≥72 patientsAzole Antifungal7.9%Itraconazole72%Fluconazole12%Posaconazole10%Voriconazole6%Part D<11 patients+ 6 more classes in this area
Cardiovascular
21.6%Statin6.8%Atorvastatin Calcium35%Rosuvastatin Calcium34%Pravastatin Sodium31%Part D≥24 patientsBeta blocker6.5%Metoprolol Tartrate53%Carvedilol29%Metoprolol Succinate18%Part D≥39 patients+ 6 more classes in this area
Metabolism & gastrointestinal
20.3%Corticosteroid8.2%Prednisone100%Part D≥58 patientsProton pump inhibitor7.7%Pantoprazole Sodium84%Omeprazole17%Part D≥54 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical utilization and culture concordance of categorical and semiquantitative concentration values on the BioFire <sup>®</sup> Pneumonia Panel at a major academic quaternary referral center
Baylor University Medical Center Proceedings
2025 - Hyperammonemia After Lung Transplantation: Case Series Recognizing Factors for Diagnosis, Treatment, and Survival
The Journal of Heart and Lung Transplantation
2025 - Comparative Outcomes of Inpatient and Outpatient Lung Transplantation: Insights from the UNOS STAR Database
The Journal of Heart and Lung Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Grayburn, MD
Baylor University Medical Center
Stuart Spechler, MD
Baylor University Medical Center
Brooks Cash, MD
Baylor University Medical Center
Robert Perrillo, MD
Baylor University Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”